CompletedNot Applicable

IL-39 & IL-35 Gingival Crevicular Fluid Levels in Diabetic Patients With Generalized Periodontitis

Egypt57 participantsStarted 2023-01-01

Plain-language summary

The sudy was aiming to assess and compare GCF levels of IL-39 \& IL-35 in gingival crevicular fluid and to correlate the relationship between different patient groups before and after non-surgical therapy.

Who can participate

Age range35 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients treated with any type of medications and/ or antibiotics during the past 3 months,
✕. Pregnancy
✕. Lactation
✕. Receiving professional periodontal treatment during the past 6 months
✕. Current or former smokers

What they're measuring

GCF levels of IL-39 & IL35

Timeframe: 3 months

Effect of SRP on GCF levels of IL-39 & IL35

Timeframe: 3 MONTHS

Trial details

NCT IDNCT05880654

SponsorFayoum University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-30

View on ClinicalTrials.gov More Generalized Periodontal Disease, AVDC Stage 3 trials